Atotech is a leading specialty chemicals technology company and a market leader in advanced electroplating solutions. Atotech delivers chemistry, equipment, software, and services for innovative technology applications through an integrated systems-and-solutions approach. Atotech solutions are used in a wide variety of end-markets, including smartphones and other consumer electronics, communications infrastructure, and computing, as well as in numerous industrial and consumer applications such as automotive, heavy machinery, and household appliances.
Atotech, headquartered in Berlin, Germany, is a team of 4,000 experts in over 40 countries generating annual revenues of $1.2 billion (2019). Atotech has manufacturing operations across Europe, the Americas, and Asia. With its well-established innovative strength and industry-leading global TechCenter network, Atotech delivers pioneering solutions combined with unparalleled on-site support for over 8,000 customers worldwide.
(US) Williams Industrial Services Group has been safely helping plant owners and operators enhance asset value for more than 50 years. The Company provides a broad range of construction, maintenance and modification, and support services to customers in energy and industrial end markets. Williams' mission is to be the preferred provider of construction, maintenance, and specialty services through commitment to superior safety performance, focus on innovation, and dedication to delivering unsurpassed value to its customers.
IMC is an MCO in the medical cannabis sector headquartered in Israel and with operations In Israel and Germany. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry.
In Europe, IMC operates through Adjupharm GmbH ("Adjupharm"), a German-based subsidiary and EU-GMP certified medical cannabis distributor. IMC's European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.
(US) stem holdings, inc., together with its subsidiaries, operates as a vertically integrated cannabis operating company. it purchases, improves, leases, operates, and invests in properties for use in the production, distribution, and sale of cannabis and cannabis-infused products under the laws of the states of oregon, nevada, california, massachusetts, maryland, and oklahoma. as of september 30, 2020, the company had ownership interests in 22 state issued cannabis licenses, including 9 licenses for cannabis cultivation; 3 licenses for cannabis production; 5 licenses for cannabis processing; 1 license for cannabis wholesale distribution; 1 license for hemp production; and 10 cannabis dispensary licenses. stem holdings, inc. was founded in 2016 and is headquartered in boca raton, florida.
sonic foundry (nasdaq: sofo) is the trusted global leader for video capture, management and webcasting solutions in education, business and government. the patented mediasite enterprise video platform transforms communications, training, education and events for more than 3,800 customers in 65 countries. sonic foundry is a leader in aragon research’s globe for video content management, frost & sullivan’s lecture capture leader for seven consecutive years, a leader in forrester’s enterprise video platforms and webcasting wave and a challenger in gartner’s magic quadrant for enterprise video content management.
mymetics corporation (otcqb: mymx) is a swiss based biotechnology company, with a research lab in the netherlands, focused on the development of next-generation preventative vaccines for infectious diseases. it has currently has 5 vaccines in its pipeline: hiv-1/aids, intra-nasal influenza, malaria, herpes simplex virus and the rsv vaccine. mymetics’ core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. the company’s vaccines are designed to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense, which, for some pathogens, may be essential for the development of an effective prophylactic vaccine. the company’s unique approach is being validated through partnerships with leading pharmaceutical or research organizations, including astellas pharma, path-mvi and the bill an
(SE) oasmia pharmaceutical ab develops a new generation of drugs within human and veterinary oncology. the product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. the product development is based on in-house research within nanotechnology and company patents.
passur aerospace is a leader in aviation business intelligence, providing cost saving and security solutions to leading airports, airlines, business aviation organizations, and the u.s. government. passur is focused on reducing the multi-billion dollar costs related to the structural and operational inefficiencies of the national air system (nas) in the us and abroad, including aviation delays and cancellations, as well as improving the safety and security of the airspace. passur data and software solutions are powered by a unique, independent network of over 140 company -owned airspace surveillance systems, and include integrated aviation databases, predictive analytics, decision support software, and performance reporting and analysis solutions.
sharing economy international inc. focuses on technology and global sharing economy markets by developing online platforms and rental business partnerships. its platforms includes buddigo, a peer-to-peer resource sharing platform that allows users to outsource daily chores and mundane tasks; and anyworkspace, an online real-time marketplace that connects workspace providers with clients who need temporary office and meeting spaces. the company also operates rental stations that offer power bank for mobile charging on-demand and other items; provides advertising services; and develops virtual tours for the real estate, hospitality, and interior design industries. in addition, it engages in real estate and property management businesses; provision of management services; online media and advertising business; and production of films. further, the company develops and operates a sharing economy mobile platform for courier services; develops an interactive virtual tour of a physical space
Founded in 2006, Israel-based IceCure Medical develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally-invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide, after receiving FDA and CE approvals.
Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Immunocore’s most advanced oncology therapeutic candidate, tebentafusp, has demonstrated an overall survival benefit in a randomized Phase 3 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies.
(AU) medica... the only nhs-equivalent reporting solution in the uk through our nighthawk, dayhawk, and routine services, we are the leading independent uk provider of radiology reporting, delivering in excess of 1 million reports a year. our reputation has been built on the provision of high-quality, fast and cost-effective teleradiology reporting services with our clients’ needs at the centre of everything we do. medica is a designated body, providing support in all aspects for the radiologist to achieve gmc revalidation. the medical director, dr stephen davies, is the responsible officer. get the flexibility and rewards you deserve today with medica: medica is currently expanding its network of radiologists to help continue to deliver first class teleradiology reporting services to the nhs and independent healthcare providers. a medica radiologist benefits from the flexibility of working hours, the convenience of working from their own home and all within a comprehensive clinical
PROCEPT is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. PROCEPT designed Aquablation therapy to deliver effective, safe and durable outcomes for males suffering from lower urinary tract symptoms, or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. PROCEPT has developed a significant and growing body of clinical evidence, which includes nine clinical studies and over 100 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
(US) q2earth inc, formerly q2power technologies, inc., is engaged in manufacturing of compost and engineered soils from recycled waste for the agriculture, horticulture, construction and infrastructure sectors. the company, through acquisitions, is focused on creating and marketing beneficial reuse end products. the company provides green waste hauling under long term contracts, and then manufactures and sells high quality soils to customers that include scotts miracle-gro, old castle and large scale agricultural firms. the company, through its subsidiary george b. wittmer associates inc. (gbwa), is a residual waste management and compost manufacturing company. gbwa services multiple paper mills in the southeast united states.